KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $34.90 million. The enterprise value is $16.01 million.

Market Cap	34.90M
Enterprise Value	16.01M

Important Dates

The last earnings date was Monday, March 31, 2025, before market open.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 6.09 million shares outstanding. The number of shares has increased by 56.09% in one year.

Current Share Class	6.09M
Shares Outstanding	6.09M
Shares Change (YoY)	+56.09%
Shares Change (QoQ)	+1.45%
Owned by Insiders (%)	3.40%
Owned by Institutions (%)	21.40%
Float	3.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.83
P/TBV Ratio	2.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 2.62.

Current Ratio	3.11
Quick Ratio	3.02
Debt / Equity	2.62
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.99

Financial Efficiency

Return on equity (ROE) is -388.29% and return on invested capital (ROIC) is -57.17%.

Return on Equity (ROE)	-388.29%
Return on Assets (ROA)	-45.36%
Return on Invested Capital (ROIC)	-57.17%
Return on Capital Employed (ROCE)	-104.95%
Revenue Per Employee	n/a
Profits Per Employee	-$895,605
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.73% in the last 52 weeks. The beta is -1.73, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-1.73
52-Week Price Change	-28.73%
50-Day Moving Average	7.62
200-Day Moving Average	6.64
Relative Strength Index (RSI)	31.94
Average Volume (20 Days)	19,942

Short Selling Information

The latest short interest is 274,816, so 4.51% of the outstanding shares have been sold short.

Short Interest	274,816
Short Previous Month	284,149
Short % of Shares Out	4.51%
Short % of Float	7.90%
Short Ratio (days to cover)	7.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.43M
Pretax Income	-38.72M
Net Income	-38.51M
EBITDA	-40.18M
EBIT	-40.43M
Earnings Per Share (EPS)	-$10.15

Full Income Statement

Balance Sheet

The company has $51.18 million in cash and $32.25 million in debt, giving a net cash position of $18.93 million or $3.11 per share.

Cash & Cash Equivalents	51.18M
Total Debt	32.25M
Net Cash	18.93M
Net Cash Per Share	$3.11
Equity (Book Value)	12.33M
Book Value Per Share	2.02
Working Capital	35.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.38 million and capital expenditures -$208,000, giving a free cash flow of -$29.59 million.

Operating Cash Flow	-29.38M
Capital Expenditures	-208,000
Free Cash Flow	-29.59M
FCF Per Share	-$4.86

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-56.09%
Shareholder Yield	-56.09%
Earnings Yield	-110.22%
FCF Yield	-84.69%

Analyst Forecast

The average price target for KALA BIO is $15.00, which is 161.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	161.78%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2